Drug-drug Interaction Study of CHF5993 With Cimetidine

NCT02287272 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: CHF 5993 pMDI
DRUG: Cimetidine plus CHF5993 pMDI

Sponsor

Chiesi Farmaceutici S.p.A.